Maribel Pereiras, PharmD, BCPS, BCOP on 1/23/19
The presentation included an overview of the biosimilar development pathway, the regulatory requirements for biosimilars, the prescribing practices and interchangeability for biosimilars, the safety mechanisms for proper dispensing and administration, the safety and efficacy data, the naming structure, and resources on biologics and biosimilars.
For more information, Dr. Pereiras has provided a follow up reference based on the questions she received at the end of the presentation.
Wiland et al. Reumatologia 2018;56, 4:234-242